for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Recipharm AB (publ)

RECIb.ST

Latest Trade

154.80SEK

Change

-4.60(-2.89%)

Volume

240,876

Today's Range

152.50

 - 

160.00

52 Week Range

107.60

 - 

166.90

As of on the Stockholm Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Recipharm Q4 EBITDA Up At SEK 367 Million

Feb 20 (Reuters) - Recipharm AB (publ) <RECIb.ST>::RECIPHARM AB PUBLISHES REPORT FOR THE FOURTH QUARTER AND FULL YEAR 2019.PROPOSED DIVIDEND IS SEK 1.60 (1.25) PER SHARE.Q4 EBITDA SEK 367 MILLION VERSUS SEK 280 MILLION YEAR AGO.Q4 NET SALES AMOUNTED TO SEK 1,981 MILLION (1,739).DEVELOPMENT & TECHNOLOGY PROFIT WAS ADVERSELY AFFECTED BY A LESS FAVOURABLE PRODUCT MIX AND CERTAIN STOCK SITUATIONS.EBITDA WAS IMPACTED BY POSITIVE AND NEGATIVE ONE-TIME EFFECTS, WITH A POSITIVE NET OF CLOSE TO SEK 10 MILLION..

Recipharm Announces That Consort Medical Applies For Delisting

Feb 6 (Reuters) - Recipharm AB (publ) <RECIb.ST>::RECIPHARM ANNOUNCES THAT CONSORT MEDICAL APPLIES FOR DELISTING.RECIPHARM - CONSORT TO APPLY TO UK LISTING AUTHORITY AND LONDON STOCK EXCHANGE REQUESTING CANCELLATION OF LISTING OF CONSORT SHARES.ANY REMAINING CONSORT SHAREHOLDERS WILL BECOME MINORITY SHAREHOLDERS IN A PRIVATELY CONTROLLED LIMITED COMPANY.

Recipharm: Consort Medical Becomes Part Of The Recipharm Group

Feb 5 (Reuters) - Recipharm AB (publ) <RECIb.ST>::CONSORT MEDICAL BECOMES PART OF THE RECIPHARM GROUP.CONSORT'S 2,000 EMPLOYEES AND 10 FACILITIES ACROSS UK, ITALY AND GERMANY WILL BECOME PART OF RECIPHARM GROUP..CONSORT'S FINANCIALS WILL BE CONSOLIDATED INTO RECIPHARM'S ACCOUNTS FROM FEBRUARY 2020.CONSORT'S FINANCIALS WILL BE CONSOLIDATED INTO RECIPHARM'S ACCOUNTS FROM FEBRUARY 2020 AND HENCE BE INCLUDED IN RECIPHARM'S Q1.TRANSACTION IS FULLY FINANCED THROUGH BANK FACILITIES, INCLUDING A BRIDGE FACILITY OF SEK 2,000 MILLION.IN ORDER TO REPAY BRIDGE FACILITY, AND TO LOWER NET DEBT, CO INTENDS TO CARRY OUT ONE OR SEVERAL SHARE ISSUES OF AT LEAST SEK 2,500 MILLION IN TOTAL WHEREOF AT LEAST SEK 2,000 MILLION THROUGH A RIGHTS ISSUE, WITH PREFERENTIAL RIGHTS FOR CO'S SHAREHOLDERS.SHARE ISSUES ARE EXPECTED TO BE RESOLVED AND COMPLETED DURING FIRST HALF OF 2020.

Recipharm Says It Will Not Extend Acceptance Deadline Beyond Feb 4 For Consort Medical Offer

Jan 29 (Reuters) - Recipharm AB <RECIb.ST>: :CONFIRMS THAT IT WILL NOT EXTEND ACCEPTANCE DEADLINE BEYOND FEB 4 FOR CONSORT MEDICAL OFFER.CONFIRMS THAT OFFER PRICE OF 1,010 PENCE PER CONSORT MEDICAL SHARE IS FINAL AND WILL NOT BE INCREASED.GOT WRITTEN NOTICE FROM IRISH COMPETITION AND CONSUMER PROTECTION COMMISSION THAT CONSORT DEAL MAY BE PUT INTO EFFECT.

Recipharm Extends Acceptance Period For Offer To Acquire Consort Medical

Jan 24 (Reuters) - Consort Medical PLC <CSRT.L>::RECIPHARM FURTHER EXTENDS THE ACCEPTANCE PERIOD FOR THE OFFER TO ACQUIRE CONSORT MEDICAL AND UPDATES ON LEVEL OF ACCEPTANCE.OFFER IS BEING EXTENDED AND WILL REMAIN OPEN FOR ACCEPTANCES UNTIL 4 FEBRUARY 2020.

Recipharm Acquires Shares In Consort Medical

Jan 22 (Reuters) - Recipharm AB (publ) <RECIb.ST>::RECIPHARM ACQUIRES SHARES IN CONSORT MEDICAL.ACQUIRED 4,881,437 CONSORT SHARES, 9.9% OF SHARE CAPITAL OF CONSORT AND FURTHER 118,563 CONSORT SHARES, REPRESENTING 0.2%.

Recipharm Gets Clearance From German Competition Authorities For Offer To Acquire Consort Medical

Jan 14 (Reuters) - Recipharm AB <RECIb.ST>::RECIPHARM RECEIVES COMPETITION CLEARANCE FROM GERMAN COMPETITION AUTHORITIES FOR THE OFFER TO ACQUIRE CONSORT MEDICAL.COMPLETION OF OFFER REMAINS SUBJECT TO OTHER OUTSTANDING CONDITIONS, SUCH AS IRISH ANTITRUST CONDITION AND ACCEPTANCE CONDITION, AS SET OUT IN OFFER DOCUMENT.

Recipharm Partners With Aptahem For Formulation Of Apta-1 Drug Candidate

Dec 17 (Reuters) - Recipharm AB (publ) <RECIb.ST>::PARTNERS WITH APTAHEM FOR FORMULATION OF APTA-1 DRUG CANDIDATE.WILL DEVELOP AN INJECTABLE FORMULATION FOR UPCOMING PHASE 1 STUDY.

Recipharm: Larger Institutional Shareholders Support Co's Cash Offer For Consort Medical And Subsequent Rights Issue

Nov 26 (Reuters) - Recipharm AB (publ) <RECIb.ST>::LARGER INSTITUTIONAL SHAREHOLDERS SUPPORT RECIPHARM'S CASH OFFER FOR CONSORT MEDICAL AND SUBSEQUENT RIGHTS ISSUE.FÖRSTA AP-FONDEN, LANNEBO FONDER AND FJÄRDE AP-FONDEN (HOLDING TOGETHER 19.6%), SUPPORT CASH OFFER FOR CONSORT MEDICAL.

Aptahem Enters Agreement With Recipharm

Nov 20 (Reuters) - Aptahem AB <APTA.TE>::ENTERS AGREEMENT WITH RECIPHARM.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up